# Localized Evidence of Cytokine Adsorption Therapy During Pediatric Cardiac Surgery: A Single Center Randomized Controlled Trial (LEAT)

Study · id `cardio:ct-nct07771491` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07771491](<https://clinicaltrials.gov/study/NCT07771491>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07771491

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT07771491. Randomized; no masking; primary purpose supportive care. Start 2026-10-01 (anticipated); primary completion 2028-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT07771491, source copy `cardio:ctgov-nct07771491-2026-08-18`, retrieved 2026-10-26)
- Planned start: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT07771491, source copy `cardio:ctgov-nct07771491-2026-08-18`, retrieved 2026-10-26)
- Primary completion: 2028-10-31 (anticipated) (ClinicalTrials.gov record NCT07771491, source copy `cardio:ctgov-nct07771491-2026-08-18`, retrieved 2026-10-26)
- Completion: 2028-10-31 (anticipated) (ClinicalTrials.gov record NCT07771491, source copy `cardio:ctgov-nct07771491-2026-08-18`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07771491-2026-08-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Localized Evidence of Cytokine Adsorption Therapy During Pediatric Cardiac Surgery: A Single Center Randomized Controlled Trial (LEAT)
- Acronym: LEAT
- Condition: Congenital Heart Disease
- Condition: Open Heart Surgery
- Condition: Cardiopulmonary Bypass
- Condition: Endocarditis Acute and Subacute
- Condition: Cyanotic Heart Disease
- Intervention (Device): Hemoadsorption (Jafron HA-60/HA380)
- Lead sponsor: Norfaniza Zabidi
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)

## Provenance

Content hash: 7e66a814d8bd5d4bb669515abaa296c3c6495d230d5890b4e8e8606251827d21
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
